{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:59:45Z","timestamp":1761166785319,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.pupt.2021.102108","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T23:33:43Z","timestamp":1639697623000},"page":"102108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia"],"prefix":"10.1016","volume":"72","author":[{"given":"Yuri","family":"Isaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5718-5120","authenticated-orcid":false,"given":"Yasutaka","family":"Hirasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Shionoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-8968","authenticated-orcid":false,"given":"Yuichiro","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Koshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.pupt.2021.102108_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.pupt.2021.102108_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2021.102108_bib4","doi-asserted-by":"crossref","first-page":"173947","DOI":"10.1016\/j.ejphar.2021.173947","article-title":"No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial","volume":"897","author":"Jamaati","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pupt.2021.102108_bib5","first-page":"21260755","article-title":"Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial","author":"Munch","year":"2021","journal-title":"medRxiv : the preprint server for health Sci."},{"key":"10.1016\/j.pupt.2021.102108_bib6","first-page":"1","article-title":"High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study","author":"Vecchi\u00e9","year":"2021","journal-title":"Intern. Emerg. Med."},{"issue":"6","key":"10.1016\/j.pupt.2021.102108_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/1744666X.2021.1919086","article-title":"The role of IL-6 and IL-6 blockade in COVID-19","volume":"17","author":"Potere","year":"2021","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"12","key":"10.1016\/j.pupt.2021.102108_bib8","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00134-017-4919-5","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"43","author":"Annane","year":"2017","journal-title":"Intensive Care Med."},{"issue":"16","key":"10.1016\/j.pupt.2021.102108_bib9","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.pupt.2021.102108_bib10","first-page":"659","article-title":"Reference spirometric values using techniques and equipment that meet ATS recommendations","volume":"123","author":"Crapo","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"issue":"3","key":"10.1016\/j.pupt.2021.102108_bib11","first-page":"419","article-title":"Lung volumes in healthy nonsmoking adults","volume":"18","author":"Crapo","year":"1982","journal-title":"Bull. Eur. Physiopathol. Respir."},{"issue":"11","key":"10.1016\/j.pupt.2021.102108_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13128","article-title":"Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships","volume":"21","author":"Popkin","year":"2020","journal-title":"Obes. Rev."},{"issue":"18","key":"10.1016\/j.pupt.2021.102108_bib15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","author":"Brower","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2021.102108_bib16","first-page":"1","article-title":"Obesity as a risk factor for severe COVID-19: summary of the best evidence and implications for","author":"Sattar","year":"2021","journal-title":"Curr. Obes. Rep."},{"issue":"1","key":"10.1016\/j.pupt.2021.102108_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40200-021-00779-2","article-title":"Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Saha","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"issue":"10229","key":"10.1016\/j.pupt.2021.102108_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.pupt.2021.102108_bib19","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; metcovid): a randomized, double-blind, phase IIb, placebo-controlled trial","volume":"72","author":"Jeronimo","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pupt.2021.102108_bib20","first-page":"1","article-title":"Potential adverse effects of dexamethasone therapy on COVID-19 patients: review and recommendations","author":"Chen","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.pupt.2021.102108_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13313","article-title":"COVID-19 infection, progression, and vaccination: focus on obesity and related metabolic disturbances","author":"Westheim","year":"2021","journal-title":"Obes. Rev."},{"issue":"13","key":"10.1016\/j.pupt.2021.102108_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136764","article-title":"Dexamethasone for severe COVID-19: how does it work at cellular and molecular levels?","volume":"22","author":"Kino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.pupt.2021.102108_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J. Heart Lung Transplant."},{"issue":"7","key":"10.1016\/j.pupt.2021.102108_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1586\/eri.11.56","article-title":"Immunomodulatory therapy for severe influenza","volume":"9","author":"Darwish","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"2","key":"10.1016\/j.pupt.2021.102108_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/cc10082","article-title":"Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus","volume":"15","author":"Kil","year":"2011","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.pupt.2021.102108_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13054-020-03415-2","article-title":"Knowledge translation tools to guide care of non-intubated patients with acute respiratory illness during the COVID-19 Pandemic","volume":"25","author":"Leasa","year":"2021","journal-title":"Crit. Care"},{"issue":"6","key":"10.1016\/j.pupt.2021.102108_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1377\/hlthaff.2020.00426","article-title":"The potential health care costs and resource use associated with COVID-19 in the United States","volume":"39","author":"Bartsch","year":"2020","journal-title":"Health Aff."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:30:43Z","timestamp":1761082243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553921001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":24,"alternative-id":["S1094553921001206"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102108","relation":{},"ISSN":["1094-5539"],"issn-type":[{"type":"print","value":"1094-5539"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102108"}}